Atea Pharmaceuticals Competitors and Similar CompaniesClear all
Chrysalis BioTherapeutics's competitors and similar companies include Adagio Therapeutics and Ipsen.
 Chrysalis BioTherapeutics ChrysalisBioTherapeutics is a biopharmaceutical company developing regenerative drugs. |  Adagio Therapeutics Adagio is a clinical-stage biopharmaceutical company focusing on the discovery and development of antibody-based solutions for infectious diseases with pandemic potential. | ||
Founding Date | Founding Date 2012 | Founding Date 2020 | Founding Date 1929 |
Type | Type Private | Type Public | Type Public |
Tags | |||
Locations | Locations Galveston, US HQ | Locations Waltham, US HQ | Locations Boulogne-Billancourt, FR HQ Algiers, DZ South Yarra, AU Wien, AT Merelbeke, BE São Paulo, BR Mississauga, CA see more |
Employees | Employees 6 | Employees 74 | Employees 5,358 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 516.2 m | Valuation ($) 10.2 b |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $53.4m (FY, 2025) | Revenue (est.) €3.7b (FY, 2025) |
Net income | Net income N/A | Net income ($52.5m) (FY, 2025) | Net income €445.1m (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 11m | Total funding raised $ 466m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Adagio Therapeutics
HQ
Waltham, US
Employees
74
Adagio is a clinical-stage biopharmaceutical company focusing on the discovery and development of antibody-based solutions for infectious diseases with pandemic potential.
View company